Activist 13D/13G Filings - UBS ASSET MANAGEMENT AMERICAS INC

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2020-02-12
10:12 am
Purchase
13GIRONWOOD PHARMACEUTICALS INC C
IRWD
UBS ASSET MANAGEMENT AMERICAS INC11,181,451
7.13%
2,589,772increase
(+30.14%)
View
2020-02-12
10:02 am
Sale
13GLEXICON PHARMACEUTICALS INC CO
LXRX
UBS ASSET MANAGEMENT AMERICAS INC616,908
5%
-187,891decrease
(-23.35%)
View
2019-06-07
5:18 pm
Unchanged
13GLEXICON PHARMACEUTICALS INC CO
LXRX
UBS ASSET MANAGEMENT AMERICAS INC804,799
6.95%
0
(Unchanged)
View
2019-06-07
2:34 pm
Sale
13GLEXICON PHARMACEUTICALS INC CO
LXRX
UBS ASSET MANAGEMENT AMERICAS INC804,799
6.95%
-183,390decrease
(-18.56%)
View
Goto Prev, 0, 1